Haya Ascher‐Svanum

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

Haya Ascher‐Svanum, Douglas E. Faries, Baojin Zhu et al. · The Journal of Clinical Psychiatry · 2006 · 488 citations

Medicine, Pharmacotherapy, Psychiatry +17

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

R. Conley, Haya Ascher‐Svanum, Baojin Zhu et al. · Schizophrenia Research · 2006 · 294 citations · Full text

Medicine, Psychiatry, Psychology +14

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries et al. · BMC Psychiatry · 2010 · 280 citations · Full text

Medicine, Pharmacoeconomics, Psychiatry +14

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Douglas E. Faries, Haya Ascher‐Svanum, Baojin Zhu et al. · BMC Psychiatry · 2005 · 183 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

Bruce J. Kinon, Lei Chen, Haya Ascher‐Svanum et al. · Neuropsychopharmacology · 2009 · 179 citations

Medicine, Pharmacotherapy, Psychiatry +15